Topics

Articles

Acquisition expected to help provide customers with a quicker clinical trial recruitment process

Five-year, nearly $90 million deal revolves around bulk drug substance formulation for Providence’s future shot

Latest construction plan continues CDMO’s vision for biopharma expansion 

Collaboration earns Adaptimmune an initial payday of $150 million

Supply deal with Takeda to begin distribution in early 2022, pending shot approval 

Drug maker to supply European Union with 60 million doses by end of Q3

Swiss organization will take patient-centric approach towards developing injectables

Agreement will focus on developing, manufacturing and commercializing biosimilars in the respiratory space

Meeting future expectations in pharmaceutical sustainability a key component of shipping collaboration

Project will center on equipment and technology improvements, says UK R&D and manufacturing accelerator 